Stryker Operating Income 2010-2024 | SYK

Stryker annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Stryker operating income for the quarter ending December 31, 2024 was $581M, a 53.78% decline year-over-year.
  • Stryker operating income for the twelve months ending December 31, 2024 was $3.689B, a 5.12% decline year-over-year.
  • Stryker annual operating income for 2024 was $3.689B, a 5.12% decline from 2023.
  • Stryker annual operating income for 2023 was $3.888B, a 36.85% increase from 2022.
  • Stryker annual operating income for 2022 was $2.841B, a 9.95% increase from 2021.
Stryker Annual Operating Income
(Millions of US $)
2024 $3,689
2023 $3,888
2022 $2,841
2021 $2,584
2020 $2,223
2019 $2,713
2018 $2,537
2017 $2,297
2016 $2,175
2015 $1,861
2014 $1,246
2013 $1,256
2012 $1,741
2011 $1,686
2010 $1,751
2009 $1,594
Stryker Quarterly Operating Income
(Millions of US $)
2024-12-31 $581
2024-09-30 $1,085
2024-06-30 $1,051
2024-03-31 $972
2023-12-31 $1,257
2023-09-30 $931
2023-06-30 $965
2023-03-31 $735
2022-12-31 $814
2022-09-30 $808
2022-06-30 $772
2022-03-31 $447
2021-12-31 $819
2021-09-30 $574
2021-06-30 $732
2021-03-31 $459
2020-12-31 $749
2020-09-30 $859
2020-06-30 $-20
2020-03-31 $635
2019-12-31 $944
2019-09-30 $628
2019-06-30 $613
2019-03-31 $528
2018-12-31 $698
2018-09-30 $576
2018-06-30 $672
2018-03-31 $591
2017-12-31 $714
2017-09-30 $525
2017-06-30 $502
2017-03-31 $556
2016-12-31 $670
2016-09-30 $486
2016-06-30 $500
2016-03-31 $519
2015-12-31 $648
2015-09-30 $378
2015-06-30 $429
2015-03-31 $406
2014-12-31 $468
2014-09-30 $450
2014-06-30 $197
2014-03-31 $131
2013-12-31 $430
2013-09-30 $150
2013-06-30 $290
2013-03-31 $386
2012-12-31 $370
2012-09-30 $450
2012-06-30 $445
2012-03-31 $476
2011-12-31 $418
2011-09-30 $444
2011-06-30 $401
2011-03-31 $423
2010-12-31 $386
2010-09-30 $471
2010-06-30 $448
2010-03-31 $446
2009-12-31 $514
2009-09-30 $311
2009-06-30 $390
2009-03-31 $379
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $147.454B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $223.673B 26.90
Boston Scientific (BSX) United States $152.309B 38.13
EssilorLuxottica (ESLOY) France $127.910B 0.00
Medtronic (MDT) Ireland $108.054B 15.78
Lonza Group Ag (LZAGY) Switzerland $48.940B 0.00
Haleon (HLN) United Kingdom $46.883B 26.67
ResMed (RMD) United States $36.216B 27.20
GE HealthCare Technologies (GEHC) United States $33.352B 15.84
Agilent Technologies (A) United States $31.795B 21.00
Terumo (TRUMY) Japan $28.308B 36.77
Insulet (PODD) United States $22.619B 88.79
Koninklijke Philips (PHG) Netherlands $22.446B 16.14
Zimmer Biomet Holdings (ZBH) United States $18.861B 12.11
Baxter (BAX) United States $15.559B 11.62
Smith & Nephew SNATS (SNN) United Kingdom $12.250B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $6.641B 22.45
Lantheus Holdings (LNTH) United States $5.453B 13.75
Prestige Consumer Healthcare (PBH) United States $4.220B 18.85
Perrigo (PRGO) Ireland $3.576B 9.06
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.449B 15.02
ICU Medical (ICUI) United States $3.346B 24.67
Envista Holdings (NVST) United States $3.039B 25.25
QuidelOrtho (QDEL) United States $2.269B 15.60
GN Store Nord (GNNDY) Denmark $2.150B 17.81
LeMaitre Vascular (LMAT) United States $1.875B 41.92
AtriCure (ATRC) United States $1.597B 0.00
Neogen (NEOG) United States $1.385B 17.72
AdaptHealth (AHCO) United States $1.200B 12.19
Green Thumb Industries (GTBIF) United States $1.173B 26.38
Kestra Medical Technologies (KMTS) United States $1.150B 0.00
BioLife Solutions (BLFS) United States $1.047B 0.00
InMode (INMD) Israel $1.013B 9.28
Phibro Animal Health (PAHC) United States $0.946B 12.10
Evolus (EOLS) United States $0.644B 0.00
CeriBell (CBLL) United States $0.595B 0.00
Curaleaf Holdings (CURLF) Canada $0.585B 0.00
Owens & Minor (OMI) United States $0.541B 4.49
Valneva SE (VALN) France $0.536B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.504B 0.00
Tilray Brands (TLRY) Canada $0.444B 0.00
Surmodics (SRDX) United States $0.399B 0.00
Capricor Therapeutics (CAPR) United States $0.350B 0.00
Cresco Labs (CRLBF) United States $0.341B 0.00
SNDL (SNDL) Canada $0.336B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
VAREX IMAGING (VREX) United States $0.307B 11.29
Sanuwave Health (SNWV) United States $0.293B 0.00
Aurora Cannabis (ACB) Canada $0.283B 50.40
Sanara MedTech (SMTI) United States $0.278B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
Verano Holdings (VRNOF) United States $0.261B 0.00
Canopy Growth (CGC) Canada $0.259B 0.00
ZimVie (ZIMV) United States $0.243B 11.04
Cerus (CERS) United States $0.239B 0.00
Omeros (OMER) United States $0.229B 0.00
Biote (BTMD) United States $0.216B 6.06
Brainsway (BWAY) Israel $0.194B 51.35
High Tide (HITI) Canada $0.190B 0.00
OraSure Technologies (OSUR) United States $0.186B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.38
Quanterix (QTRX) United States $0.166B 0.00
Organigram Global (OGI) Canada $0.163B 0.00
TriSalus Life Sciences (TLSI) United States $0.158B 0.00
FitLife Brands (FTLF) United States $0.139B 17.18
Exagen (XGN) United States $0.124B 0.00
TerrAscend (TSNDF) Canada $0.118B 0.00
Agape ATP (ATPC) $0.105B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
MacroGenics (MGNX) United States $0.098B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Fonar (FONR) United States $0.076B 10.64
Veru (VERU) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
Quipt Home Medical (QIPT) United States $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.84
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.022B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.018B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00